XML 102 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
12 Months Ended
Sep. 30, 2013
SEGMENT INFORMATION

11. SEGMENT INFORMATION

We report our continuing operations in three operating segments: Fine Chemicals, Specialty Chemicals, and Other Businesses. These segments are based upon business units that offer distinct products and services, are operationally managed separately and produce products using different production methods. Segment operating income or loss includes all sales and expenses directly associated with each segment. Environmental remediation charges, corporate general and administrative costs, which consist primarily of executive, investor relations, accounting, human resources and information technology expenses, and interest are not allocated to segment operating results.

Fine Chemicals. Our Fine Chemicals segment includes the operating results of our wholly-owned subsidiaries Ampac Fine Chemicals LLC and AMPAC Fine Chemicals Texas, LLC (collectively, “AFC”). AFC is a custom manufacturer of active pharmaceutical ingredients and registered intermediates for commercial customers in the pharmaceutical industry. AFC operates in compliance with the U.S. Food and Drug Administration’s current Good Manufacturing Practices and the requirements of certain other regulatory agencies such as the European Union’s European Medicines Agency and Japan’s Pharmaceuticals and Medical Devices Agency. AFC also complies with Drug Enforcement Administration requirements related to the manufacture and sale of certain controlled substances. AFC has distinctive competencies and specialized engineering capabilities in performing chiral separations, manufacturing chemical compounds that require high containment, performing energetic chemistries at large scale, and manufacturing Schedule II controlled substances.

Specialty Chemicals. Our Specialty Chemicals segment manufactures and sells: (i) perchlorate chemicals, principally ammonium perchlorate, which is the predominant oxidizing agent for solid propellant rockets, booster motors and missiles used in space exploration, commercial satellite transportation and national defense programs, (ii) sodium azide, a chemical used in pharmaceutical manufacturing, and (iii) Halotron®, a series of clean fire extinguishing agents used in fire extinguishing products ranging from portable fire extinguishers to total flooding systems.

 

Other Businesses. Our Other Businesses segment contains our water treatment equipment division and real estate activities. Our water treatment equipment business markets, designs, and manufactures electrochemical On Site Hypochlorite Generation, or OSHG, systems. These systems are used in the disinfection of drinking water, control of noxious odors, and the treatment of seawater to prevent the growth of marine organisms in cooling systems. We supply our equipment to municipal, industrial and offshore customers. Our real estate activities are not material.

Our revenues are characterized by individually significant orders and relatively few customers. As a result, in any given reporting period, certain customers may account for more than 10% of our consolidated revenues. The following table provides disclosure of the percentage of our consolidated revenues attributed to customers that exceed 10% of the total in each of the fiscal years ended September 30:

 

 

 

 

 
    2013      2012      2011  
 

 

 

 

Fine chemicals customer

    28%         31%         23%   

Fine chemicals customer

       12%      

Specialty chemicals customer

       17%      

Specialty chemicals customer

    20%         12%         24%   

The following provides financial information about our segment operations for the fiscal years ended September 30:

 

 

 

 

 
    2013     2012     2011  
 

 

 

 

Revenues:

     

Fine Chemicals

  $ 124,898      $ 111,536      $ 89,497   

Specialty Chemicals

    82,636        68,513        66,905   

Other Businesses

    7,551        5,578        4,312   
 

 

 

 

Total Revenues

  $ 215,085      $ 185,627      $ 160,714   
 

 

 

 

Segment Operating Income (Loss):

     

Fine Chemicals

  $ 11,295      $ 8,678      $ (6,283

Specialty Chemicals

    47,961        34,919        35,600   

Other Businesses

    (1,066     (473     (1,308
 

 

 

 

Total Segment Operating Income

    58,190        43,124        28,009   

Corporate Expenses

    (17,101     (14,326     (14,124

Environmental Remediation Charges

    -        (700     (6,000
 

 

 

 

Operating Income

  $ 41,089      $ 28,098      $ 7,885   
 

 

 

 

Depreciation and Amortization:

     

Fine Chemicals

  $ 12,013      $ 11,914      $ 12,473   

Specialty Chemicals

    1,144        1,401        1,136   

Other Businesses

    21        18        17   

Corporate

    275        367        432   
 

 

 

 

Total

  $ 13,453      $ 13,700      $ 14,058   
 

 

 

 

Capital Expenditures:

     

Fine Chemicals

  $ 11,138      $ 7,383      $ 11,153   

Specialty Chemicals

    2,661        1,353        756   

Other Businesses

    6        18        8   

Corporate

    111        34        14   
 

 

 

 

Total

  $ 13,916      $ 8,788      $ 11,931   
 

 

 

 

Assets, at year end:

     

Fine Chemicals

  $ 154,707      $ 143,551      $ 144,003   

Specialty Chemicals

    27,427        21,029        19,785   

Other Businesses

    5,319        7,302        5,064   

Corporate

    89,854        74,582        60,954   
 

 

 

 

Total

  $ 277,307      $ 246,464      $ 229,806   
 

 

 

 

 

All of our continuing operations are located in the United States. Export sales consist mostly of fine chemicals and water treatment equipment sales. For the year ended September 30, 2013, sales outside the U.S. represented 43% of consolidated revenues. Of this amount 19% was sold to customers in Ireland, with no other individual country representing more than 10%. For the year ended September 30, 2012, sales outside the U.S. represented 36% of consolidated revenues. Of this amount, 17% was sold to customers in Ireland and 12% sold to customers in Belgium, with no other individual country representing more than 10%. For the year ended September 30, 2011, sales outside the U.S. represented 25% of consolidated revenues, with no individual country representing more than 10%.